Tanai Therapeutics appoints Pieter Rottiers as Chief Executive Officer

Tanai Therapeutics appoints Pieter Rottiers as Chief Executive Officer

January 22, 2025
VIB spin-off Muna Therapeutics Announces Strategic Alliance with GSK to Accelerate Development of Novel Treatments for Alzheimer’s Disease

VIB spin-off Muna Therapeutics Announces Strategic Alliance with GSK to Accelerate Development of Novel Treatments for Alzheimer’s Disease

December 6, 2024

VUB and VIB launch new Bio Incubator Brussels on VUB campus

VUB and VIB launch new Bio Incubator Brussels on VUB campus

Catalyst for collaboration and biotechnological innovation

December 5, 2024

Innovating in the world of oncology through RNA therapeutics

Innovating in the world of oncology through RNA therapeutics

December 3, 2024

ExeVir Announces Michael Garrett as New Chief Executive Officer

ExeVir Announces Michael Garrett as New Chief Executive Officer

Company developing antibody therapeutics against emerging viral threats

November 18, 2024

Zymofix secures €2 million to scale microbial solutions for sustainable agriculture and beyond

Zymofix secures €2 million to scale microbial solutions for sustainable agriculture and beyond

• Additional financing to advance proprietary fermentation technology • Looking to expand the team to support its rapid growth • Rebranded from N-Fix to Zymofix – learn more at Zymofix.com

November 12, 2024

Protealis Secures 1.2m EUR VLAIO grants to Advance Local High-Performing Legume Crop Innovations in Northern Europe

Protealis Secures 1.2m EUR VLAIO grants to Advance Local High-Performing Legume Crop Innovations in Northern Europe

November 6, 2024

Confo Therapeutics Announces Publication in Nature Communications Demonstrating First-Ever Structure of a Complex Between an Antibody-based Agonist and a Class A GPCR Regulating Hunger and Satiety

Confo Therapeutics Announces Publication in Nature Communications Demonstrating First-Ever Structure of a Complex Between an Antibody-based Agonist and a Class A GPCR Regulating Hunger and Satiety

October 1, 2024

Tanai Therapeutics secures additional financing from Novo Nordisk and BioGeneration Ventures for novel obesity drug

Tanai Therapeutics secures additional financing from Novo Nordisk and BioGeneration Ventures for novel obesity drug

September 19, 2024

European Soy Industry Gathered in Ghent, Belgium during most Northern Soy Field Event

European Soy Industry Gathered in Ghent, Belgium during most Northern Soy Field Event

Protealis Hosted First Soy Field Day Event in Belgium to Highlight Innovations in Northern European Soy Cultivation

September 12, 2024

Contact us

Lies Vanneste

Lies Vanneste

Investor Relations Manager, VIB
IR@vib.be+32 498 05 35 79

Get updates in your mailbox

By clicking "Subscribe" I confirm I have read and agree to the Privacy Policy.

About VIB

VIB is a leading life sciences research institute based in Belgium, renowned for its work in medical sciences, plant biology, microbiology, artificial intelligence and biotechnology. VIB's mission is to push the boundaries of scientific discovery, transform it into disruptive biotech innovations and support the growth of the life sciences ecosystem in Flanders (Belgium). VIB is a partnership with Ghent University, Hasselt University, KU Leuven, University of Antwerp, and Vrije Universiteit Brussel.

VIB drives the translation of research discoveries into innovative products and technologies for patients, consumers and society. It does so by launching new spin-offs, licensing intellectual property to companies, engaging in dynamic partnerships and fostering talent development. VIB has created 39 spin-offs in the healthcare and agrifood sectors, attracting over €1.8 billion in equity investment and has partnered intensely with industry, generating over €350 million in income. VIB’s research has led to dozens of innovative products brought to market for medical, agriculture, and food applications, with many more in development. Seven of its spin-off companies have reached the clinical stage.

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1, 9052 Zwijnaarde

IR@vib.be

www.vib.be